Outlook Therapeutics, Inc. announced a private placement of 714,286 shares at a price of $7 per share for the gross proceeds of $5,000,002 and accompanying warrant to purchase one and a half shares of common stock on April 15, 2024. The warrants have an exercise price of $7.70 per share of common stock and will expire on April 15, 2029. The transaction included participation from returning investor,
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.1 USD | +7.95% | +12.48% | +15.48% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.48% | 196M | |
+1.77% | 42.75B | |
+47.70% | 41.61B | |
+12.24% | 41.34B | |
-8.83% | 26.59B | |
+7.44% | 25.49B | |
-23.01% | 18.12B | |
+30.56% | 12.24B | |
-1.82% | 11.76B | |
+8.35% | 11B |
- Stock Market
- Equities
- OTLK Stock
- News Outlook Therapeutics, Inc.
- Outlook Therapeutics, Inc. announced that it has received $5.000002 million in funding from Syntone Ventures LLC